Disruption of CDKL5, resulting in decreased activity, leads to CDKL5 deficiency disorder (CDD), a rare and severe condition classified as a developmental epileptic encephalopathy [15,16]. This evidence concerns the gene CDKL5 and craniodiaphyseal dysplasia.